Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic lupus erythematosus (SLE), providing further evidence that the emerging ...

Bristol Myers Squibb is paying Prime Medicine $110 million upfront to develop reagents for ex vivo T-cell therapies. Prime, which could receive a whopping $3.5 billion in milestones, disclosed the ...

CAR-T therapies have been around for six years, but it was only in January that Bristol Myers Squibb unveiled the first positive readout for such a personalized immunotherapy in chronic lymphocytic ...

Hyundai Motor Group (HMG) said it planned to make its battery management system (BMS) available in all its forthcoming electric vehicles (EVs) to alleviate growing concerns over battery safety ...

Organizations and emergency management agency directors from three flood-stricken counties in the region were honored as ...

Burning mouth syndrome (BMS) is a chronic condition characterized by a burning pain in the mouth, sometimes accompanied by numbness. The clinical features of this condition closely resemble other ...